Ensuring Uptake of Vaccines Against SARS-CoV-2

Illustration of people in white medical face masks. Concept of coronavirus quarantine vector illustration.

(This op-ed was first published in The New England Journal of Medicine on June 26, 2020.)

As Covid-19 continues to exact a heavy toll, development of a vaccine appears the most promising means of restoring normalcy to civil life. Perhaps no scientific breakthrough is more eagerly anticipated. But bringing a vaccine to market is only half the challenge; also critical is ensuring a high enough vaccination rate to achieve herd immunity. Concerningly, a recent poll found that only 49% of Americans planned to get vaccinated against SARS-CoV-2.1

(Continue reading the op-ed on The New England Journal of Medicine’s page here.)